Oct 27 (Reuters) - Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR ...
Teva Pharmaceuticals and AbbVie’s Allergan followed the lead of retail pharmacy chains to allot billions of dollars to settle nationwide opioid lawsuits, according to North Carolina Attorney General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback